WORLDWIDE GENETIC POLYMORPHISM OF CIRCUMSPOROZOITE PROTEIN IN PLASMODIUM VIVAX SEQUENCES: A SYSTEMATIC REVIEW

WORLDWIDE GENETIC POLYMORPHISM OF CIRCUMSPOROZOITE PROTEIN IN PLASMODIUM VIVAX SEQUENCES: A SYSTEMATIC REVIEW

The Circumsporozoite Protein of Plasmodium vivax (PvCSP) is an immunodominant antigen expressed on the surface of the sporozoite. PvCSP consists of a central repetitive region (CRR), capable of stimulating both T and B lymphocytes. The CRR is flanked by two non-repetitive regions, N-terminal (RI) an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marrara Pereira Sampaio, Marcelo Cerilo-Filho, Yasmin de Goés, Maria Naely Gomes Almeida, Rayanne Iane Correa, Nathália Faria Reis, Andréa Regina de Souza Baptista, Ricardo Luiz Dantas Machado
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867024006846
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

POLYMORPHISMS IN THE CYP-450 GENE AND MALARIA: A GENOTYPIC AND PHENOTYPIC RELATIONSHIP WITH THERAPEUTIC FAILURE
by: Marcelo Cerilo-Filho, et al.
Published: (2024-11-01)

CAN THE RS2234246 POLYMORPHISM IN THE TREM-1 GENE BE RELATED TO THE CLINICAL COURSE IN INDIVIDUALS INFECTED WITH PLASMODIUM VIVAX IN AN ENDEMIC AREA OF THE BRAZILIAN AMAZON?
by: Marcelo Cerilo-Filho, et al.
Published: (2024-11-01)

Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development
by: Pascal S. Krenger, et al.
Published: (2024-11-01)

Lipid Profile of Children with Malaria by Plasmodium vivax
by: Rosa Maria Dias, et al.
Published: (2016-01-01)

Epidemiology of Plasmodium vivax malaria infection in Colombia
by: Mario J. Olivera, et al.
Published: (2024-12-01)

Thrombocytopenia in Plasmodium vivax Malaria: How Significant?
by: Arti Muley, et al.
Published: (2014-01-01)

Complicated congenital malaria due to Plasmodium vivax
by: Angélica María Díaz-Contreras, et al.
Published: (2015-07-01)

Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy
by: Naveen Yadav, et al.
Published: (2024-12-01)

Plasmodium vivax antigen candidate prediction improves with the addition of Plasmodium falciparum data
by: Renee Ti Chou, et al.
Published: (2024-11-01)

Hemophagocytic Lymphohistiocytosis Complicating Dengue and Plasmodium vivax Coinfection
by: Muhammad Khurram, et al.
Published: (2015-01-01)

Genomic exploration of the journey of Plasmodium vivax in Latin America.
by: Margaux J M Lefebvre, et al.
Published: (2025-01-01)

Human liver organoids are susceptible to Plasmodium vivax infection
by: Norapat Nitaramorn, et al.
Published: (2024-12-01)

Retraction: The Plasmodium circumsporozoite protein, a novel NF-κB inhibitor, suppresses the growth of SW480
by: Pathology and Oncology Research Editorial Office
Published: (2024-11-01)

Congenital Malaria due to Plasmodium Vivax Infection in a Neonate
by: Ravi Bhatia, et al.
Published: (2016-01-01)

Plasmodium vivax Infection in Multiple Family Members in Texas, USA
by: Roukaya Al Hammoud, et al.
Published: (2019-01-01)

Mathematical models of Plasmodium vivax transmission: A scoping review.
by: Md Nurul Anwar, et al.
Published: (2024-03-01)

YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
by: Inés Bouzón-Arnáiz, et al.
Published: (2025-01-01)

Genetic diversity of Plasmodium falciparum and Plasmodium vivax field isolates from the Nowshera district of Pakistan
by: Chandni Hayat, et al.
Published: (2024-11-01)

N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
by: Fernanda G. Versiani, et al.
Published: (2013-01-01)

Genetic diversity of Plasmodium vivax and Plasmodium falciparum field isolates from Honduras in the malaria elimination phase
by: Alejandro Zamora, et al.
Published: (2025-01-01)

Imported malaria cases by Plasmodium falciparum and Plasmodium vivax in Mexican territory: Potential impact of the migration crisis
by: Miguel Ángel Loyola-Cruz, et al.
Published: (2024-11-01)

Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi.
by: Alice O Andrade, et al.
Published: (2023-06-01)

Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand
by: Parsakorn Tapaopong, et al.
Published: (2025-01-01)

Genomic analysis of global Plasmodium vivax populations reveals insights into the evolution of drug resistance
by: Gabrielle C. Ngwana-Joseph, et al.
Published: (2024-12-01)

AUTOMATED HEMATOLOGY ANALYZERS IN DIAGNOSIS OF PLASMODIUM VIVAX MALARIA: AN ADJUNCT TO CONVENTIONAL MICROSCOPY.
by: Kolakkadan Mubeen Hasaf, et al.
Published: (2014-05-01)

Salivary Glands Proteins Expression of Anopheles dirus A Fed on Plasmodium vivax- and Plasmodium falciparum-Infected Human Blood
by: Saowanee Cotama, et al.
Published: (2013-01-01)

An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors.
by: Suélen Fernandes Silva, et al.
Published: (2024-12-01)

Investigation on Plasmodium falciparum and Plasmodium vivax Infection Influencing Host Haematological Factors in Tribal Dominant and Malaria Endemic Population of Jharkhand
by: Mohammad Raziuddin, et al.
Published: (2014-08-01)

High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes
by: Zachary R. Popkin-Hall, et al.
Published: (2024-11-01)

Deep learning-based malaria parasite detection: convolutional neural networks model for accurate species identification of Plasmodium falciparum and Plasmodium vivax
by: Diego A. Ramos-Briceño, et al.
Published: (2025-01-01)

IgM against Merozoite Surface Protein 1-Block 2 Haplotypes as New Tools for Plasmodium vivax Infections
by: Fernanda de Almeida Batalha, et al.
Published: (2024-12-01)

Chloroquine-primaquine therapeutic response and safety in patients with uncomplicated Plasmodium vivax malaria in the Colombian Amazon region
by: Paula Calderón-Ruiz, et al.
Published: (2024-11-01)

Contribution of Travelers to <i>Plasmodium Vivax</i> Malaria in South West Delhi, India: Cross-Sectional Survey
by: Deepali Savargaonkar, et al.
Published: (2025-01-01)

Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
by: Anna C. Winnicki, et al.
Published: (2024-12-01)

Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
by: Jun Yong Choi, et al.
Published: (2021-02-01)

Characteristics of Plasmodium vivax apicomplexan amino acid transporter 8 (PvApiAT8) in the cationic amino acid transport
by: Wang-Jong Lee, et al.
Published: (2025-02-01)

Evaluation of the transmission-blocking potential of Plasmodium vivax antigen Pvg37 using transgenic rodent parasites and clinical isolates
by: Di Zhang, et al.
Published: (2025-01-01)

Relative efficacy of anti-Plasmodium vivax malaria combination drugs in preventing transmission to two major Anopheles mosquitoes in the first few days of treatment
by: Erika Gómez Martinez, et al.
Published: (2025-01-01)

Burden and clinical characteristics of recurrent Plasmodium vivax infections, and impact of primaquine for radical cure: a systematic scoping review in India
by: Loick Pradel Kojom Foko, et al.
Published: (2024-12-01)

The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia
by: Lionel B. Feufack-Donfack, et al.
Published: (2024-11-01)